EXACT SCIENCES CORP
Company Information
Industry Services-Medical Laboratories
SIC Code 8071
Entity Type operating
SEC Category Large accelerated filer
Business Address 5505 ENDEAVOR LANE, MADISON, WI, 53719
Mailing Address 5505 ENDEAVOR LANE, MADISON, WI, 53719
Phone 608-284-5700
Fiscal Year End 1231
EIN 200478229
Financial Overview
FY2025
-$204.15M
Net Income
$5.93B
Total Assets
$3.53B
Total Liabilities
$956.00M
Cash & Equivalents
$-1.10
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | February 13, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 13, 2026 | View on SEC |
| 10-K Annual financial report | February 13, 2026 | View on SEC |
| 8-K Current report of material events | February 10, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | January 16, 2026 | View on SEC |
| 4 Insider stock transaction report | December 30, 2025 | View on SEC |
| 4 Insider stock transaction report | December 30, 2025 | View on SEC |
| 4 Insider stock transaction report | December 30, 2025 | View on SEC |
| 4 Insider stock transaction report | December 30, 2025 | View on SEC |
| 4 Insider stock transaction report | December 30, 2025 | View on SEC |
Annual Reports
10-K February 13, 2026
- Exact Sciences achieved robust 17% revenue growth to $3.2 billion, driven by strong Cologuard adoption and expanded precision oncology offerings.
- The company is making significant strategic investments ($700M R&D, $1.5B SG&A) in innovation, acquisitions, and market expansion to fuel future growth in cancer diagnostics.
Related Companies
Companies in the same industry (SIC: 8071)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.